27 April 2017
News and Views
Links and Services
The most recent issue of the Inflammatory Bowel Diseases reports that biological treatments may be cost-effective for Crohn's disease under certain clinical scenarios.
Identifying clinical scenarios that maximize the cost-effectiveness of biological treatments can
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors